News

Investing.com -- Societe Generale told clients in a note on Tuesday that U.S. earnings strength is broadening beyond technology, and it expects the S&P 500 to reach 8,000, urging investors to "buy the momentum dip."

(Updates with economic data, recent oil price movement, world markets' overview and corporate stock

PSEG (PEG) delivered earnings and revenue surprises of +7.50% and -5.38%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

NRG (NRG) delivered earnings and revenue surprises of -10.24% and +27.02%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

ImmunityBio (IBRX) delivered earnings and revenue surprises of +11.11% and +5.76%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

The online home goods retailer beat Wall Street expectations on revenue and earnings as U.S. sales grew 8.7% year over year

Elon Musk is tying SpaceX and Tesla closer together, amid speculation of an eventual merger. Both stocks are up on Tuesday morning.

Full-year revenue guidance raised to $8.15 billion from $7.65 billion

Palantir's AI Growth Is Accelerating. Wall Street Just Raised Its Price Target

Hut 8’s revenue rose 81% but fell short of consensus, while cryptocurrency valuation losses drove a wider-than-expected GAAP loss.

Qnity Electronics, Inc. (NYSE:Q) reported second-quarter 2026 results that comfortably surpassed Wall Street expectations and raised its financial guidance for the full year, sending the company’s shares 10.

Moby summary of Vertex Pharmaceuticals Incorporated's Q2 2026 earnings call

Moby summary of Voyager Technologies, Inc.'s Q2 2026 earnings call

Moby summary of Powell Industries, Inc.'s Q3 2026 earnings call

Moby summary of Kosmos Energy Ltd.'s Q2 2026 earnings call

Moby summary of Ichor Holdings, Ltd.'s Q2 2026 earnings call

Moby summary of BWX Technologies, Inc.'s Q2 2026 earnings call

Moby summary of Adeia Inc.'s Q2 2026 earnings call

Moby summary of Diamondback Energy, Inc.'s Q2 2026 earnings call

Qnity Electronics beat Wall Street's targets for the second quarter and raised its guidance for the full year. Qnity stock rose.

Spotify Technology SA (NYSE:SPOT) shares fell around 6% in pre-market trading after the music streaming platform reported second-quarter 2026 results that missed Wall Street expectations, despite continued growth in subscribers and record gross margins. While the company delivered solid user growth and issued stronger-than-expected revenue guidance for the current quarter, weaker earnings weighed on investor sentiment.

SpaceX Heads Into Earnings With Shorts Surging and a Massive $330 Options Bet

F's Q2 earnings beat, raised 2026 guidance, improving product mix and narrowing EV losses strengthen its investment case.

Leidos Holdings Inc. (NYSE:LDOS) reported second-quarter 2026 results that comfortably exceeded Wall Street expectations, prompting the defence and technology contractor to raise its financial outlook for the full year.

Wayfair (W) delivered earnings and revenue surprises of +1.06% and +1.52%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

McDonald's (MCD) delivered earnings and revenue surprises of +1.81% and -0.51%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Entegris (ENTG) delivered earnings and revenue surprises of +12.05% and +5.16%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Bruker (BRKR) delivered earnings and revenue surprises of +28.95% and -2.18%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Cipher began collecting rent at Black Pearl two months early and completed an $810 million secured notes offering to fund Stingray, while its Texas development pipeline expanded near San Antonio.

Merck (NYSE:MRK) shares moved higher in pre-market trading after the pharmaceutical company reported second-quarter 2026 results that exceeded Wall Street expectations and raised its full-year revenue guidance. Although Merck reduced its adjusted earnings outlook to reflect acquisition-related charges, investors welcomed the stronger-than-expected quarterly performance and improved sales forecast.